View:     View:
tid Target Cancers General Effect on Target
Name
Source
Type

TrxR1 or TXNRD1 (Thioredoxin Reductase 1)
• Many studies have found that an elevated expression of TrxR1 in breast tumors, NSCLC, HCC correlates with increased tumor aggressiveness and a poorer prognosis.
-TrxR1 expression was elevated by >50 fold in FaDu and HeLa cells, and by >20 fold in SCC-1 compared to either MSK-Leuk1 or keratinocytes.

• High TrxR1 levels have been associated with resistance to chemotherapy in some subtypes.




(Will delete Record if Target field = "Delete")
 Home